BRNS vs CLOV
Barinthus Biotherapeutics plc (BRNS) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BRNS revenue for 2024-12-31 was $15.0M. Net income was -$61.2M. Revenue was up 1766.5% from 2023-12-31 to 2024-12-31. BRNS currently screens at market cap $38.2M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BRNS currently screens at market cap $38.2M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BRNS and CLOV stock pages for the full models.
Not investment advice.